Jet-Based Needle-Free Injectors Market

Needleless Injection is a technique that allows drugs to be delivered through the skin, effectively eliminating the use of subcutaneous needles.Injection-based needle-free syringes inject drugs in the form of a spray.This technology is of great benefit to the growing pharmaceutical industry and is useful in mass immunization programmes because it reduces the chance of needle stick injuries and other complications, including those resulting from multiple use of a single needle.

Jet-Based Needle-Free Injectors Market contains market size and forecasts of Jet-Based Needle-Free Injectors in global, including the following market information:

• Global Jet-Based Needle-Free Injectors Market Revenue, 2017-2022, 2023-2028, ($ millions)
• Global Jet-Based Needle-Free Injectors Market Sales, 2017-2022, 2023-2028, (K Units)
• Global top five Jet-Based Needle-Free Injectors companies in 2021 (%)

The global Jet-Based Needle-Free Injectors market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Disposable Needle-Free Injectors Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Jet-Based Needle-Free Injectors include PharmaJet, Antares Pharma, Endo International PLC, Injex Pharma AG, European Pharma Group(InsuJet), Portal Instruments, PenJet Corporation, Crossject and J-Tip. etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Jet-Based Needle-Free Injectors manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Jet-Based Needle-Free Injectors Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Jet-Based Needle-Free Injectors Market Segment Percentages, by Type, 2021 (%)

• Disposable Needle-Free Injectors
• Reusable Needle-Free Injectors

Global Jet-Based Needle-Free Injectors Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Jet-Based Needle-Free Injectors Market Segment Percentages, by Application, 2021 (%)

• Hospitals and Clinics
• Home Care Settings
• Research Laboratories
• Pharmaceutical and Biotechnological Companies
• Others

Global Jet-Based Needle-Free Injectors Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Jet-Based Needle-Free Injectors Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies Jet-Based Needle-Free Injectors revenues in global market, 2017-2022 (Estimated), ($ millions)
• Key companies Jet-Based Needle-Free Injectors revenues share in global market, 2021 (%)
• Key companies Jet-Based Needle-Free Injectors sales in global market, 2017-2022 (Estimated), (K Units)
• Key companies Jet-Based Needle-Free Injectors sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• PharmaJet
• Antares Pharma
• Endo International PLC
• Injex Pharma AG
• European Pharma Group(InsuJet)
• Portal Instruments
• PenJet Corporation
• Crossject
• J-Tip